2014 |
The Group has commenced the business of a retail pharmacy store and trading of wines. |
2013 |
The Group disposed of its certain assets relating to the electronic cigarette business to Imperial Tobacco at the consideration of US$75million. |
2012 |
The Group improved and upgraded the production facilities of health care products. |
2011
|
The Group commenced property investment by acquiring the entire issued share capital of Central Town Limited for the interests of a commercial premises in Hong Kong. |
2010
|
The patent application (number 10/587,707) for electronic atomization cigarette has been approved in the United States by the United States Patent And Trademark Office. |
2009
|
Azithromycin Granules (II) has been listed in the National List of Essential Drugs (2009 Edition). |
2008
|
The electronic cigarette products won two of the six awards presented at the 2008 Tobacco Plus Expo held at the Las Vegas Convention Centre on 24 and 25 April 2008. The Company’s electronic cigarette was named 2008’s most innovative product and its Ruyan Vegas E-cigar was named the most marketable product of the year. |
The Group launched the new Ruyan Jazz® disposable electronic cigarette. |
2007
|
The Group acquired the entire issued share capital of Best Partners Worldwide Limited (presently known as Ruyan Investment (Holdings) Limited) for Ruyan, at a consideration of approximately RMB1,274 million. |
2006
|
Approval was granted to produce Hai Te Ling. |
2005
|
Two product lines were established for the electronic cigarettes component. |
2004
|
Shenyang Jinlong Health Care Products Company Limited has become the wholly-owned subsidiary of the Company. |
2003
|
Approval was granted to produce Azithromycin Granules in September 2003 and it was launched in the market in October 2003. In December 2003, the Group also obtained approval to produce Piglyketone which was launched in the market in December 2004. |
2002
|
The State Pharmaceutical Supervision and Administration Bureau of the PRC approved the change of registration reference of Longevity Ginseng from Liao Wei Jian Zi (1996) No. 0136 to Guo Yao Zhan Zi No. B20021010 in December 2002. |
2001
|
The shares of the Company were listed on the main board of The Stock Exchange of Hong Kong Limited on 9 May 2001. |